Towarzystwo Funduszy Inwestycyjnych PZU SA’s Idexx Laboratories IDXX Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	411 +40	+11%	+$22.4K	0.06%	193
2026 Q1	$208K	Sell	371 -59	-14%	-$37.8K	0.07%	178
2025 Q4	$291K	Hold	430	–	–	0.07%	150
2025 Q3	$275K	Buy	430 +35	+9%	+$21.2K	0.07%	142
2025 Q2	$212K	Hold	395	–	–	0.06%	156
2025 Q1	$166K	Hold	395	–	–	0.06%	161
2024 Q4	$163K	Hold	395	–	–	0.05%	148
2024 Q3	$200K	Hold	395	–	–	0.07%	119
2024 Q2	$192K	Sell	395 -50	-11%	-$25.1K	0.07%	117
2024 Q1	$240K	Hold	445	–	–	0.1%	90
2023 Q4	$247K	Buy	+445	New	+$209K	0.11%	77
2021 Q3	$261K	Sell	420 -20	-5%	-$13.4K	0.31%	40
2021 Q2	$278K	Hold	440	–	–	0.33%	40
2021 Q1	$215K	Buy	440 +40	+10%	+$20K	0.31%	45
2020 Q4	$200K	Buy	+400	New	+$179K	0.21%	48

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's IDXX Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $22.4K and bringing the position to 411 shares worth $216K. The position accounts for 0.06% of the portfolio, ranked #193.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in IDXX in Q4 2020 and has held it in 15 quarters since. The position peaked at $291K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 411 shares of Idexx Laboratories worth $216K as of Q2 2026.
Towarzystwo Funduszy Inwestycyjnych PZU SA bought 40 Idexx Laboratories shares in Q2 2026, an estimated $22.4K.
Idexx Laboratories made up 0.06% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #193 holding.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Idexx Laboratories in Q4 2020 and has held it in 15 quarters since.
Towarzystwo Funduszy Inwestycyjnych PZU SA's Idexx Laboratories position peaked at $291K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.